300 related articles for article (PubMed ID: 3370062)
1. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
Lesne M
Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
Delarge J
Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
[TBL] [Abstract][Full Text] [Related]
3. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Brunner G; von Bergmann K; Häcker W; von Möllendorff E
Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics and pharmacodynamics of torasemide.
Knauf H; Mutschler E
Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
[TBL] [Abstract][Full Text] [Related]
6. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
Dupont AG; Gerlo E; Van der Niepen P; Laekeman G; Piepsz A
Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of torasemide in healthy volunteers.
Lameire N; Dodion L
Arzneimittelforschung; 1988 Jan; 38(1A):167-71. PubMed ID: 3370064
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of torasemide in man.
Neugebauer G; Besenfelder E; von Möllendorff E
Arzneimittelforschung; 1988 Jan; 38(1A):164-6. PubMed ID: 3370063
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.
Lesne M; Clerckx-Braun F; Duhoux P; van Ypersele de Strihou C
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):382-7. PubMed ID: 7118326
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
Kramer WG
Cardiology; 1994; 84 Suppl 2():108-14. PubMed ID: 7954532
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
[TBL] [Abstract][Full Text] [Related]
12. Torasemide in advanced renal failure.
Kindler J
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
[TBL] [Abstract][Full Text] [Related]
13. Dose-response curve for torasemide in healthy volunteers.
Scheen AJ
Arzneimittelforschung; 1988 Jan; 38(1A):156-9. PubMed ID: 3370061
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of the high ceiling diuretic torasemide in rats and dogs.
Ghys A; Denef J; Delarge J; Georges A
Arzneimittelforschung; 1985; 35(10):1527-31. PubMed ID: 4074408
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
Mourad G; Haecker W; Mion C
Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of the new potent diuretic torasemide in rats and dogs.
Ghys A; Denef J; de Suray JM; Gerin M; Georges A; Delarge J; Willems J
Arzneimittelforschung; 1985; 35(10):1520-6. PubMed ID: 4074407
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of loop diuretics.
Brater DC
Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
[TBL] [Abstract][Full Text] [Related]
18. A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.
Barbanoj MJ; Ballester MR; Antonijoan RM; Puntes M; Gropper S; Santos B; Albet C; Guglietta A
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):469-77. PubMed ID: 19673928
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Kult J; Häcker W; Glocke M
Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
[TBL] [Abstract][Full Text] [Related]
20. The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.
Knauf H; Spahn H; Mutschler E
Drugs; 1991; 41 Suppl 3():23-34. PubMed ID: 1712713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
